SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: flickerful who wrote (256)12/9/1997 7:11:00 PM
From: 5,17,37,5,101,...  Read Replies (2) | Respond to of 756
 
Well, my first positions in a security are almost always very small because I have found that shortly after the initial purchase the price drops like a rock. I then average down and when it seems to be a nightmarishly good deal, I leverage to the hilt [another point lower in Ivax would trigger such a move]. On the way down I learn all I can about the company before leveraging. I am very comfortable with Ivax. I know next to nothing about RATL except about the insider buys [which are enormously!! bullish!! here]. As for class action suits...they are usually an opportunity to buy at bargain prices. The parties usually settle for a pitance of which insurance picks up most of the tab. A c.a. suit against IDTI wouldn't surprise me, if the stock should drop a few more points, then we really begin the buying.

I would be a tad more infatuated with the recent insider IVX buys if Bethune had placed a larger bet along with a few VP's and O's who had exercized some nonqualified options. But it looks promising.
Enough verbosity,
Jackson